title: Molecular pathology of the cell cycle in human cancer cells.
abstract: Recent evidence from molecular biology studies of the cell cycle machinery suggests that, apart from oncogenes and tumor suppressor genes, the genes encoding the key cell cycle regulatory proteins could serve as additional targets for oncogenic mutations involved in the multistep process of carcinogenesis. In an attempt to identify such potential cancer-associated aberrations of the cell cycle regulators, the expression of cdc2 and cdk2 kinases, as well as cyclins A, B1 and D1, was analyzed by immunoblotting in a panel of more than 40 human cancer cell lines derived from 17 different tumor types. The expression of cdc2, cdk2, cyclin B1 and cyclin A polypeptides was detectable in all lines examined, and moderate variation in protein level does not provide evidence for any obvious abnormalities in the cancer cell lines studied. The application of a series of novel monoclonal antibodies (Mab) to human cdc2 revealed the existence of an intriguing protein, designated p37, immunologically and structurally related to cdc2, which is strongly and selectively expressed in about 50% of the cancer cell lines. In contrast to cyclin A, which has also been implicated in tumorigenesis, we found pronounced variation in abundance of the cyclin D1 protein. Our data suggest that dysregulation of cyclin D1 (a candidate bcl-1, PRAD1 oncogene) can be involved in the pathogenesis of some additional tumor types (e.g., sarcomas and neuroblastomas) besides those reported for amplification and/or mRNA overexpression of this oncogene.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Tumour Biology, Institute of Haematology and Blood Transfusion, Prague, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Bártek
authors.forename: Z
authors.initials: Z
authors.lastname: Stasková
authors.forename: G
authors.initials: G
authors.lastname: Draetta
authors.forename: J
authors.initials: J
authors.lastname: Lukás
mesh_terms: D000818:Animals; D016203:CDC2 Protein Kinase / Q000235:genetics; D042846:CDC2-CDC28 Kinases; D002453:Cell Cycle / Q000235:genetics*; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases; D016213:Cyclins / Q000235:genetics; D005260:Female; D006801:Humans; D015151:Immunoblotting; D051379:Mice; D008807:Mice, Inbred BALB C; D009363:Neoplasm Proteins / Q000235:genetics; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D011494:Protein Kinases / Q000235:genetics; D017346:Protein Serine-Threonine Kinases; D014407:Tumor Cells, Cultured
chemical_list: D016213:Cyclins; D009363:Neoplasm Proteins; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; D016203:CDC2 Protein Kinase; D042846:CDC2-CDC28 Kinases; C495894:CDK2 protein, human; C495893:Cdk2 protein, mouse; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases